Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma

The overall response rates and long-term survival of primary central nervous system lymphoma (PCNSL) are still significantly inferior to the results achieved in similar subtypes of extranodal non-Hodgkin's lymphoma. It is clearly necessary to investigate new therapeutic methods on PCNSL. We enc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Defeng, Qian, Liren, Shen, Jianliang, Liu, Xiaopeng, Mei, Ke, Cen, Jian, Wang, Yaming, Li, Congyong, Ma, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508147/
https://www.ncbi.nlm.nih.gov/pubmed/24628986
http://dx.doi.org/10.1111/jcmm.12252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508147/
https://www.ncbi.nlm.nih.gov/pubmed/24628986
http://dx.doi.org/10.1111/jcmm.12252

Ejemplares similares